Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Monosegmental ALPPS: a long-term survival alternative to liver transplant in PRETEXT IV hepatoblastoma.

Ruiz Figueroa EF, Fernández-Placencia RM, Berrospi Espinoza FE, Gomez HF, Chávez Passiuri IK.

J Surg Case Rep. 2019 May 9;2019(5):rjz144. doi: 10.1093/jscr/rjz144. eCollection 2019 May.

2.

Analysis of blood lead levels of young children in Flint, Michigan before and during the 18-month switch to Flint River water.

Gómez HF, Borgialli DA, Sharman M, Shah KK, Scolpino AJ, Oleske JM, Bogden JD.

Clin Toxicol (Phila). 2019 Mar 14:1-8. doi: 10.1080/15563650.2018.1552003. [Epub ahead of print]

PMID:
30871386
3.

Blood Lead Levels of Children in Flint, Michigan: 2006-2016.

Gómez HF, Borgialli DA, Sharman M, Shah KK, Scolpino AJ, Oleske JM, Bogden JD.

J Pediatr. 2018 Jun;197:158-164. doi: 10.1016/j.jpeds.2017.12.063. Epub 2018 Mar 26.

PMID:
29599069
4.

Blood Lead Concentrations of Children in the United States: A Comparison of States Using Two Very Large Databases.

Shah KK, Oleske JM, Gomez HF, Davidow AL, Bogden JD.

J Pediatr. 2017 Jun;185:218-223. doi: 10.1016/j.jpeds.2017.01.059. Epub 2017 Feb 28.

PMID:
28258736
5.

The Dissociation between Polarity, Semantic Orientation, and Emotional Tone as an Early Indicator of Cognitive Impairment.

Arias Tapia SA, Martínez-Tomás R, Gómez HF, Hernández Del Salto V, Sánchez Guerrero J, Mocha-Bonilla JA, Barbosa Corbacho J, Khan A, Chicaiza Redin V.

Front Comput Neurosci. 2016 Sep 14;10:95. doi: 10.3389/fncom.2016.00095. eCollection 2016.

6.

Toward Community Standards and Software for Whole-Cell Modeling.

Waltemath D, Karr JR, Bergmann FT, Chelliah V, Hucka M, Krantz M, Liebermeister W, Mendes P, Myers CJ, Pir P, Alaybeyoglu B, Aranganathan NK, Baghalian K, Bittig AT, Burke PE, Cantarelli M, Chew YH, Costa RS, Cursons J, Czauderna T, Goldberg AP, Gomez HF, Hahn J, Hameri T, Gardiol DF, Kazakiewicz D, Kiselev I, Knight-Schrijver V, Knupfer C, Konig M, Lee D, Lloret-Villas A, Mandrik N, Medley JK, Moreau B, Naderi-Meshkin H, Palaniappan SK, Priego-Espinosa D, Scharm M, Sharma M, Smallbone K, Stanford NJ, Song JH, Theile T, Tokic M, Tomar N, Toure V, Uhlendorf J, Varusai TM, Watanabe LH, Wendland F, Wolfien M, Yurkovich JT, Zhu Y, Zardilis A, Zhukova A, Schreiber F.

IEEE Trans Biomed Eng. 2016 Oct;63(10):2007-14. doi: 10.1109/TBME.2016.2560762. Epub 2016 Jun 10.

7.

MOCCASIN: converting MATLAB ODE models to SBML.

Gómez HF, Hucka M, Keating SM, Nudelman G, Iber D, Sealfon SC.

Bioinformatics. 2016 Jun 15;32(12):1905-6. doi: 10.1093/bioinformatics/btw056. Epub 2016 Feb 9.

8.

JSBML 1.0: providing a smorgasbord of options to encode systems biology models.

Rodriguez N, Thomas A, Watanabe L, Vazirabad IY, Kofia V, Gómez HF, Mittag F, Matthes J, Rudolph J, Wrzodek F, Netz E, Diamantikos A, Eichner J, Keller R, Wrzodek C, Fröhlich S, Lewis NE, Myers CJ, Le Novère N, Palsson BØ, Hucka M, Dräger A.

Bioinformatics. 2015 Oct 15;31(20):3383-6. doi: 10.1093/bioinformatics/btv341. Epub 2015 Jun 16.

9.

Genomic models of short-term exposure accurately predict long-term chemical carcinogenicity and identify putative mechanisms of action.

Gusenleitner D, Auerbach SS, Melia T, Gómez HF, Sherr DH, Monti S.

PLoS One. 2014 Jul 24;9(7):e102579. doi: 10.1371/journal.pone.0102579. eCollection 2014.

10.

Overexpression of protein phosphatase 4 correlates with poor prognosis in patients with stage II pancreatic ductal adenocarcinoma.

Weng S, Wang H, Chen W, Katz MH, Chatterjee D, Lee JE, Pisters PW, Gomez HF, Abbruzzese JL, Fleming JB, Wang H.

Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1336-43. doi: 10.1158/1055-9965.EPI-12-0223. Epub 2012 Jun 4.

11.

Outcomes and economic analysis of routine preoperative 4-dimensional CT for surgical intervention in de novo primary hyperparathyroidism: does clinical benefit justify the cost?

Abbott DE, Cantor SB, Grubbs EG, Santora R, Gomez HF, Evans DB, Lee JE, Vu T, Perrier ND.

J Am Coll Surg. 2012 Apr;214(4):629-37; discussion 637-9. doi: 10.1016/j.jamcollsurg.2011.12.022. Epub 2012 Feb 8.

PMID:
22321526
12.

Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma.

Chatterjee D, Katz MH, Rashid A, Wang H, Iuga AC, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Crane CH, Gomez HF, Abbruzzese JL, Fleming JB, Wang H.

Am J Surg Pathol. 2012 Mar;36(3):409-17. doi: 10.1097/PAS.0b013e31824104c5.

13.

Tumor invasion of muscular vessels predicts poor prognosis in patients with pancreatic ductal adenocarcinoma who have received neoadjuvant therapy and pancreaticoduodenectomy.

Chatterjee D, Rashid A, Wang H, Katz MH, Wolff RA, Varadhachary GR, Lee JE, Pisters PW, Gomez HF, Abbruzzese JL, Fleming JB, Wang H.

Am J Surg Pathol. 2012 Apr;36(4):552-9. doi: 10.1097/PAS.0b013e318240c1c0.

14.

Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation.

Wang J, Estrella JS, Peng L, Rashid A, Varadhachary GR, Wang H, Lee JE, Pisters PW, Vauthey JN, Katz MH, Gomez HF, Evans DB, Abbruzzese JL, Fleming JB, Wang H.

Cancer. 2012 Aug 1;118(15):3801-11. doi: 10.1002/cncr.26717. Epub 2011 Dec 16.

15.

Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis.

Zhao Q, Rashid A, Gong Y, Katz MH, Lee JE, Wolf R, Balachandran A, Varadhachary GR, Pisters PW, Wang H, Gomez HF, Abbruzzese JL, Fleming JB, Wang H.

Ann Diagn Pathol. 2012 Jan;16(1):29-37. doi: 10.1016/j.anndiagpath.2011.08.005. Epub 2011 Nov 3.

16.

Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome.

Chatterjee D, Katz MH, Rashid A, Varadhachary GR, Wolff RA, Wang H, Lee JE, Pisters PW, Vauthey JN, Crane C, Gomez HF, Abbruzzese JL, Fleming JB, Wang H.

Cancer. 2012 Jun 15;118(12):3182-90. doi: 10.1002/cncr.26651. Epub 2011 Oct 25.

17.

Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation.

Estrella JS, Rashid A, Fleming JB, Katz MH, Lee JE, Wolf RA, Varadhachary GR, Pisters PW, Abdalla EK, Vauthey JN, Wang H, Gomez HF, Evans DB, Abbruzzese JL, Wang H.

Cancer. 2012 Jan 1;118(1):268-77. doi: 10.1002/cncr.26243. Epub 2011 Jul 6.

18.

Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma.

Song X, Wang H, Logsdon CD, Rashid A, Fleming JB, Abbruzzese JL, Gomez HF, Evans DB, Wang H.

Cancer. 2011 Feb 15;117(4):734-43. doi: 10.1002/cncr.25483. Epub 2010 Oct 4.

19.

High levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.

Liang JJ, Zhu S, Bruggeman R, Zaino RJ, Evans DB, Fleming JB, Gomez HF, Zander DS, Wang H.

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2598-604. doi: 10.1158/1055-9965.EPI-10-0405. Epub 2010 Aug 23.

20.

High levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinoma.

Peng L, Liang J, Wang H, Song X, Rashid A, Gomez HF, Corley LJ, Abbruzzese JL, Fleming JB, Evans DB, Wang H.

Clin Cancer Res. 2010 Jul 15;16(14):3734-42. doi: 10.1158/1078-0432.CCR-09-3411. Epub 2010 Jul 13.

21.

Mad honey sex: therapeutic misadventures from an ancient biological weapon.

Demircan A, Keleş A, Bildik F, Aygencel G, Doğan NO, Gómez HF.

Ann Emerg Med. 2009 Dec;54(6):824-9. doi: 10.1016/j.annemergmed.2009.06.010. Epub 2009 Aug 15.

PMID:
19683834
22.

The learning curve in pancreatic surgery.

Tseng JF, Pisters PW, Lee JE, Wang H, Gomez HF, Sun CC, Evans DB.

Surgery. 2007 May;141(5):694-701.

PMID:
17511115
23.
24.

The learning curve in pancreatic surgery.

Tseng JF, Pisters PW, Lee JE, Wang H, Gomez HF, Sun CC, Evans DB.

Surgery. 2007 Apr;141(4):456-63. Epub 2007 Jan 22. Corrected and republished in: Surgery. 2007 May;141(5):694-701.

PMID:
17383522
25.

Diagnosis of loxoscelism in a child confirmed with an enzyme-linked immunosorbent assay and noninvasive tissue sampling.

Stoecker WV, Green JA, Gomez HF.

J Am Acad Dermatol. 2006 Nov;55(5):888-90. Epub 2006 Sep 1.

26.

Pancreaticoduodenectomy after placement of endobiliary metal stents.

Mullen JT, Lee JH, Gomez HF, Ross WA, Fukami N, Wolff RA, Abdalla EK, Vauthey JN, Lee JE, Pisters PW, Evans DB.

J Gastrointest Surg. 2005 Nov;9(8):1094-104; discussion 1104-5.

PMID:
16269380
27.

Calcium and beta receptor antagonist overdose: a review and update of pharmacological principles and management.

Newton CR, Delgado JH, Gomez HF.

Semin Respir Crit Care Med. 2002 Feb;23(1):19-25.

PMID:
16088594
28.

Pancreaticoduodenectomy with vascular resection: margin status and survival duration.

Tseng JF, Raut CP, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Gomez HF, Sun CC, Crane CH, Wolff RA, Evans DB.

J Gastrointest Surg. 2004 Dec;8(8):935-49; discussion 949-50.

PMID:
15585381
29.

Infant botulism: a diagnostic and management challenge.

Ketcham EM, Gomez HF.

Air Med J. 2003 Sep-Oct;22(5):6-11. No abstract available.

PMID:
14671769
30.

Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli.

Ochoa TJ, Noguera-Obenza M, Ebel F, Guzman CA, Gomez HF, Cleary TG.

Infect Immun. 2003 Sep;71(9):5149-55.

31.

Human milk secretory antibodies against attaching and effacing Escherichia coli antigens.

Noguera-Obenza M, Ochoa TJ, Gomez HF, Guerrero ML, Herrera-Insua I, Morrow AL, Ruiz-Palacios G, Pickering LK, Guzman CA, Cleary TG.

Emerg Infect Dis. 2003 May;9(5):545-51.

32.

Human lactoferrin impairs virulence of Shigella flexneri.

Gomez HF, Ochoa TJ, Carlin LG, Cleary TG.

J Infect Dis. 2003 Jan 1;187(1):87-95. Epub 2002 Dec 13.

PMID:
12508150
33.

Lactoferrin protects rabbits from Shigella flexneri-induced inflammatory enteritis.

Gomez HF, Ochoa TJ, Herrera-Insua I, Carlin LG, Cleary TG.

Infect Immun. 2002 Dec;70(12):7050-3.

34.
35.

A new assay for the detection of Loxosceles species (brown recluse) spider venom.

Gomez HF, Krywko DM, Stoecker WV.

Ann Emerg Med. 2002 May;39(5):469-74.

36.

Protective role of human lactoferrin against invasion of Shigella flexneri M90T.

Gomez HF, Herrera-Insua I, Siddiqui MM, Diaz-Gonzalez VA, Caceres E, Newburg DS, Cleary TG.

Adv Exp Med Biol. 2001;501:457-67.

PMID:
11787716
37.

Human milk lipids bind Shiga toxin.

Herrera-Insua I, Gomez HF, Diaz-Gonzalez VA, Chaturvedi P, Newburg DS, Cleary TG.

Adv Exp Med Biol. 2001;501:333-9.

PMID:
11787699
38.

Hydrocarbon toxicity: General review and management guidelines.

Mickiewicz M, Gomez HF.

Air Med J. 2001 May-Jun;20(3):8-11. Review. No abstract available.

PMID:
11331818
39.

Direct correlation between diffusion of Loxosceles reclusa venom and extent of dermal inflammation.

Gomez HF, Greenfield DM, Miller MJ, Warren JS.

Acad Emerg Med. 2001 Apr;8(4):309-14.

40.

Antigenic cross-reactivity of venoms from medically important North American Loxosceles spider species.

Gomez HF, Miller MJ, Waggener MW, Lankford HA, Warren JS.

Toxicon. 2001 Jun;39(6):817-24.

PMID:
11137541
41.

Detection of Loxosceles venom in lesional hair shafts and skin: application of a specific immunoassay to identify dermonecrotic arachnidism.

Miller MJ, Gomez HF, Snider RJ, Stephens EL, Czop RM, Warren JS.

Am J Emerg Med. 2000 Sep;18(5):626-8.

PMID:
10999583
42.

Severe gamma-hydroxybutyrate withdrawal: a case report and literature review.

Craig K, Gomez HF, McManus JL, Bania TC.

J Emerg Med. 2000 Jan;18(1):65-70.

PMID:
10645841
43.

Intradermal anti-loxosceles Fab fragments attenuate dermonecrotic arachnidism.

Gomez HF, Miller MJ, Trachy JW, Marks RM, Warren JS.

Acad Emerg Med. 1999 Dec;6(12):1195-202.

44.

Loxosceles deserta spider venom induces NF-kappaB-dependent chemokine production by endothelial cells.

Desai A, Miller MJ, Gomez HF, Warren JS.

J Toxicol Clin Toxicol. 1999;37(4):447-56.

PMID:
10465241
45.
46.

Mediators of microvascular injury in dermal burn wounds.

Ravage ZB, Gomez HF, Czermak BJ, Watkins SA, Till GO.

Inflammation. 1998 Dec;22(6):619-29.

47.

Prevention of gastrointestinal iron absorption by chelation from an orally administered premixed deferoxamine/charcoal slurry.

Gomez HF, McClafferty HH, Flory D, Brent J, Dart RC.

Ann Emerg Med. 1997 Nov;30(5):587-92.

PMID:
9360566
48.

Clinical ergotism with lingual ischemia induced by clarithromycin-ergotamine interaction.

Horowitz RS, Dart RC, Gomez HF.

Arch Intern Med. 1996 Feb 26;156(4):456-8.

PMID:
8607732
49.

Postmortem acetaminophen pharmacokinetics: an experimental study of site and time-dependent concentration changes.

Gomez HF, McKinney P, Phillips S, Roberts DV, Brent J, Watson WA.

J Forensic Sci. 1995 Nov;40(6):980-2.

PMID:
8522929
50.

Incomplete hemolytic-uremic syndrome in Argentinean children with bloody diarrhea.

López EL, Contrini MM, Devoto S, de Rosa MF, Graña MG, Aversa L, Gómez HF, Genero MH, Cleary TG.

J Pediatr. 1995 Sep;127(3):364-7.

PMID:
7658263

Supplemental Content

Loading ...
Support Center